BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yokose C, Lu N, Xie H, Li L, Zheng Y, McCormick N, Rai SK, Aviña-Zubieta JA, Choi HK. Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study. CMAJ 2019;191:E1070-7. [PMID: 31570545 DOI: 10.1503/cmaj.190339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bathini L, Garg AX, Sontrop JM, Weir MA, Blake PG, Dixon SN, Mcarthur E, Muanda FT. Initiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study. American Journal of Kidney Diseases 2022. [DOI: 10.1053/j.ajkd.2022.04.006] [Reference Citation Analysis]
2 Zhao K, Xie H, Li L, Esdaile JM, Aviña-Zubieta JA. Increased risk of severe infections and mortality in patients with newly diagnosed systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 2021;60:5300-9. [PMID: 33751035 DOI: 10.1093/rheumatology/keab219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brucato A, Cianci F, Carnovale C. Management of hyperuricemia in asymptomatic patients: A critical appraisal. Eur J Intern Med 2020;74:8-17. [PMID: 31952982 DOI: 10.1016/j.ejim.2020.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
4 Fan Y, Liu W, Jin Y, Hou X, Zhang X, Pan H, Lu H, Guo X. Integrated Molecular Docking with Network Pharmacology to Reveal the Molecular Mechanism of Simiao Powder in the Treatment of Acute Gouty Arthritis. Evid Based Complement Alternat Med 2021;2021:5570968. [PMID: 34007291 DOI: 10.1155/2021/5570968] [Reference Citation Analysis]